INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.030
-0.060 (-2.87%)
At close: Aug 29, 2025, 4:00 PM
2.040
+0.010 (0.49%)
After-hours: Aug 29, 2025, 7:54 PM EDT

INmune Bio Stock Forecast

Stock Price Forecast

The 3 analysts that cover INmune Bio stock have a consensus rating of "Buy" and an average price target of $9.53, which forecasts a 369.46% increase in the stock price over the next year. The lowest target is $0.60 and the highest is $20.

Price Target: $9.53 (+369.46%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$0.60$9.53$8.00$20
Change-70.44%+369.46%+294.09%+885.22%
* Price targets were last updated on Jul 2, 2025.

Analyst Ratings

The average analyst rating for INmune Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222222
Buy111100
Hold000011
Sell000011
Strong Sell000000
Total333344

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Maintains
$30$8
Strong BuyMaintains$30$8+294.09%Jul 2, 2025
BTIG
BTIG
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 1, 2025
Scotiabank
Scotiabank
Sell
Downgrades
$23$0.6
SellDowngrades$23$0.6-70.44%Jul 1, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$22$30
Strong BuyMaintains$22$30+1,377.83%Feb 13, 2025
Scotiabank
Scotiabank
Buy
Maintains
$22$23
BuyMaintains$22$23+1,033.00%Feb 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
34.00K
from 14.00K
Increased by 142.83%
Revenue Next Year
5.06M
from 34.00K
Increased by 14,780.90%
EPS This Year
-1.50
from -2.11
EPS Next Year
-1.54
from -1.50
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
11.00K181.00K374.00K155.00K14.00K34.00K5.06M
Revenue Growth
-1,545.46%106.63%-58.56%-90.97%142.83%14,780.90%
EPS
-1.01-1.88-1.52-1.67-2.11-1.50-1.54
EPS Growth
-------
Forward PE
-------
No. Analysts
-----88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High52,50015.2M
Avg33,9975.1M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
275.0%
44,492.7%
Avg
142.8%
14,780.9%
Low--

EPS Forecast

EPS20252026202720282029
High-1.28-0.76
Avg-1.50-1.54
Low-1.56-2.51

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.